Business Context and Reporting Period
Company: Hudson Technologies, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2010
Business Overview: Hudson Technologies provides refrigerant services, including sales, reclamation, and on-site diagnostic services (RefrigerantSide® Services) for commercial and industrial refrigeration systems. The company operates in a highly regulated industry subject to Clean Air Act limitations on HCFC and CFC production.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended June 30, 2010 |
6 Months Ended June 30, 2010 |
6 Months Ended June 30, 2009 |
|---|---|---|---|
| Revenues | $16,053 | $25,137 | $14,900 |
| Gross Profit | $3,697 | $4,874 | $3,044 |
| Gross Margin | 23.0% | 19.4% | 20.4% |
| Operating Income | $2,441 | $2,278 | $590 |
| Net Income (Loss) | $1,327 | $1,057 | ($111) |
| Diluted EPS | $0.06 | $0.05 | ($0.01) |
| Cash from Operations (6mo) | $1,607 | ||
| Total Debt (Short + Long Term) | $8,784 | ||
| Cash and Equivalents | $494 | ||
| Working Capital | $7,134 |
Material Changes vs. Prior Period
- Revenue Growth: Revenues for the six months ended June 30, 2010, increased 69% to $25.1 million from $14.9 million in the prior year. This was driven primarily by a $10.2 million increase in refrigerant sales due to higher volume of pounds sold.
- Profitability: The company returned to profitability, reporting net income of $1.1 million for the six-month period compared to a net loss of $0.1 million in the same period of 2009. Operating income increased significantly to $2.3 million from $0.6 million.
- Cost Structure: Cost of sales increased 71% to $20.3 million, resulting in a slight compression of gross margin to 19.4% (from 20.4%) due to lower selling prices per pound for certain refrigerants.
- Balance Sheet: Trade accounts receivable surged to $9.0 million from $1.6 million at year-end 2009, reflecting higher sales volume. Inventory decreased to $13.0 million from $16.4 million.
- Debt: Total debt obligations increased due to the reclassification of $3.0 million of term loans from long-term to short-term as the credit facility approaches its June 2011 expiration.
Outlook, Risks, and Management Commentary
- Regulatory Environment: The company faces ongoing regulatory constraints under the Clean Air Act, which phases out virgin HCFC production by 2020-2030. Management believes sufficient quantities of new and used refrigerants will remain available but notes that supply limitations could materially affect operations.
- Seasonality: Operations are seasonal, with peak refrigerant sales typically occurring in the first half of the year. The company notes that unseasonably cool weather in 2009 had previously impacted demand.
- Liquidity: The company maintains a credit facility with Keltic Financial Partners expiring in June 2011. As of June 30, 2010, $6.0 million was available under the revolving line. Management expects to meet working capital needs through operations and available credit.
- Subsequent Event: On July 7, 2010, the company completed a registered direct offering, selling units consisting of common stock and warrants for net proceeds of approximately $4.9 million.
- Capital Expenditures: Estimated total capital expenditures for 2010 are approximately $600,000.
Investor Verification Checklist
- Debt Maturity: Verify the status of the $8.8 million in debt obligations, specifically the $3.0 million term loan reclassified as current due to the June 2011 facility expiration.
- Receivables Quality: Review the significant increase in trade receivables ($7.4 million increase) and the associated allowance for doubtful accounts to assess collection risk.
- Supply Chain: Monitor the company's ability to source HCFC and CFC refrigerants at commercially reasonable terms given regulatory phase-outs.
- Subsequent Financing: Confirm the impact of the July 2010 equity offering on the company's capital structure and cash position.
- Customer Concentration: Note that while no single customer exceeded 10% of revenue in the first half of 2010, one customer accounted for 11% in the prior year; monitor for concentration risks.